Jiafang Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiafang Fu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Guangxiang Cao
Department of Epidemiology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
2 shared publications Peipei Zhang
First Affiliated Hospital of Shandong First Medical University, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong 250117, China
2 shared publicationsGongli Zong
First Affiliated Hospital of Shandong First Medical University, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong 250117, China; Key Laboratory for Biotech-Drugs of the National Health Commission, Key Laboratory for Genetic Engineering and Synthetic Biology of Shandong Province, Ji'nan, Shandong 250117, China
1 shared publication- Gongli Zong
Key Laboratory of Industrial Biotechnology of Ministry of Education & School of Biotechnology, Jiangnan University , Wuxi, China
1 shared publication Rong Wang
First Affiliated Hospital of Shandong First Medical University, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong 250117, China
1 shared publication- Rongzhen Zhang
School of Biotechnology, Jiangnan University, Wuxi, 214122, China
1 shared publication
Latest Publications
- 12 May 2026
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 67 (8) , 107837
The ATP-binding cassette transporter CstA as a novel therapeutic target for treating carbapenem-resistant Enterobacteriaceae bacteria
- 12 May 2026
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 67 (8) , 107837
The ATP-binding cassette transporter CstA as a novel therapeutic target for treating carbapenem-resistant Enterobacteriaceae bacteria
- Open Access
- 27 October 2021
- Published by Taylor & Francis in Critical Reviews in Biotechnology
- Vol. 42 (8) , 1260-1283
Use of elicitors to enhance or activate the antibiotic production in streptomyces
Streptomyces is the largest and most significant genus of Actinobacteria, comprising 961 species. These Gram-positive bacteria produce many versatile and important bioactive compounds; of these, antibiotics, specifically the enhancement or activation of their production, have received extensive research attention. Recently, various biotic and abiotic elicitors have been reported to modify the antibiotic metabolism of Streptomyces, which promotes the production of new antibiotics and bioactive metabolites for improvement in the yields of endogenous products. However, some elicitors that obviously contribute to secondary metabolite production have not yet received sufficient attention. In this study, we have reviewed the functions and mechanisms of chemicals, novel microbial metabolic elicitors, microbial interactions, enzymes, enzyme inhibitors, environmental factors, and novel combination methods regarding antibiotic production in Streptomyces. This review has aimed to identify potentially valuable elicitors for stimulating the production of latent antibiotics or enhancing the synthesis of subsistent antibiotics in Streptomyces. Future applications and challenges in the discovery of new antibiotics and enhancement of existing antibiotic production using elicitors are discussed.
- 27 October 2021
- Published by Taylor & Francis in Critical Reviews in Biotechnology
- Vol. 42 (8) , 1260-1283
Open AccessUse of elicitors to enhance or activate the antibiotic production in streptomyces
Streptomyces is the largest and most significant genus of Actinobacteria, comprising 961 species. These Gram-positive bacteria produce many versatile and important bioactive compounds; of these, antibiotics, specifically the enhancement or activation of their production, have received extensive research attention. Recently, various biotic and abiotic elicitors have been reported to modify the antibiotic metabolism of Streptomyces, which promotes the production of new antibiotics and bioactive metabolites for improvement in the yields of endogenous products. However, some elicitors that obviously contribute to secondary metabolite production have not yet received sufficient attention. In this study, we have reviewed the functions and mechanisms of chemicals, novel microbial metabolic elicitors, microbial interactions, enzymes, enzyme inhibitors, environmental factors, and novel combination methods regarding antibiotic production in Streptomyces. This review has aimed to identify potentially valuable elicitors for stimulating the production of latent antibiotics or enhancing the synthesis of subsistent antibiotics in Streptomyces. Future applications and challenges in the discovery of new antibiotics and enhancement of existing antibiotic production using elicitors are discussed.